Tirzepatide generally produces greater average weight loss than semaglutide and is often better tolerated, although both medications have similar gastrointestinal side-effect profiles
doi: 10.1111/andr.2018.6.issue-2 211 GualtieriRKalthurGBarbatoVLongobardiSDi RellaFAdigaSKet al
Corrado advises working with an experienced provider on dose adjustments: "While clinical trials often increase doses every four weeks to the maximum, many real-world patients achieve meaningful results with slower adjustments and without ever reaching the highest dose." Talk to your doctor about whether these medications make sense for you
Pourmand G, Movahedin M, Dehghani S, Mehrsai A, Ahmadi A, Pourhosein M, Hoseini M, Ziloochi M, Heidari F, Beladi L, Noori M